Amebic liver abscess
Judith A. Anesi, Stephen Gluckman – 24 August 2015 – Watch a video presentation of this article
Hepatology highlights
Jean‐François Dufour – 24 August 2015
Hepatitis C treatment: Back to the warehouse
John P. Rice – 24 August 2015 – Watch a video presentation of this article
Pyogenic liver abscess
Sarah Longworth, Jennifer Han – 24 August 2015 – Watch a video presentation of this article
Working with palliative care services
Amanda J. Brisebois, Puneeta Tandon – 24 August 2015 – Watch a video presentation of this article
Overview of palliative care and hospice services
Sara E. Wordingham, Keith M. Swetz – 24 August 2015 – Watch a video presentation of this article
Breaking the species barrier for hepatitis delta virus
Benjamin Y. Winer, Alexander Ploss – 20 August 2015
Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ‐dependent induction and expansion of regulatory T cells in mice
Forough Khadem, Xiaoling Gao, Zhirong Mou, Ping Jia, Hesamaldin Movassagh, Chukwunonso Onyilagha, Abdelilah S. Gounni, Matthew C. Wright, Jude E. Uzonna – 20 August 2015 – Visceral leishmaniasis (VL) is associated with severe immune dysfunction and if untreated leads to death. Because the liver is one of the primary target organs in VL, unraveling the mechanisms governing the local hepatic immune response is important for understanding the immunopathogenesis of VL.
Ex vivo pancreaticoduodenectomy and liver autotransplantation for pancreatic head tumor with extensive involvement of the hepatoduodenal ligament
Nobuhide Matsuoka, Joshua I. Weiner, Adam D. Griesemer, Benjamin B. Samstein, Yejun Zhao, Jean C. Emond, Tomoaki Kato – 20 August 2015
Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists
Palak J. Trivedi, Christophe Corpechot, Albert Pares, Gideon M. Hirschfield – 20 August 2015 – Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are infrequent autoimmune cholestatic liver diseases, that disproportionate to their incidence and prevalence, remain very important causes of morbidity and mortality for patients with liver disease.